2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
Sigrun Halvorsen(Oslo University Hospital), Volkmar Falk(ETH Zurich), Kai Zacharowski(Goethe University Frankfurt), Ingrid de Laval, Stefan De Hert, Claudio Muneretto, Maya Cikes, Oktay Tutarel, Alaide Chieffo, Victoria Delgado(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Borja Ibáñez(Spanish National Centre for Cardiovascular Research), Stefanie Schüpke, Leyla Elif Sade(University of Pisa), Lucia Torracca(Humanitas University), Ingo Ahrens, Helmut Baumgartner(University Hospital Münster), P.J. Devereaux(University of Limerick), Steen Dalby Kristensen, Henrik Schirmer(ESCP Business School), Jelena Čelutkienė(Vilnius University), Harald Darius(Vivantes Klinikum), Radosław Lenarczyk(Silesian Center for Heart Disease), Héctor Bueno(Centro de Investigación en Red en Enfermedades Cardiovasculares), Trygve S. Hall, Andreas Baumbach(Queen Mary University of London), Ulrich Mansmann(Zimmer Biomet (Netherlands)), Victor Aboyans(The Princess Grace Hospital), Paul McGreavy, Emanuele Barbato(CTO Andrea Alesini), Tatjana Potpara(University of Belgrade), Juhani Knuuti(University of Turku), Julinda Mehilli, Helge Skulstad, Salvatore Cassese, Dan Atar, David Duncker, Arsen Ristić(University of Belgrade), Lynne Hinterbuchner, Tobias Geisler(Imperial College London), Magdy Abdelhamid, Peter van der Meer(University Medical Center Groningen), Christian Mueller(Immutep (Germany)), Henrik Sillesen(Rigshospitalet), Michael Böhm, Alexander Niessner
Cited by 1,063
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k